May 7, 2025 | Addictive Food Lawsuits, Child Injuries, Children's Product Liability, Defective Product, Product Liability
As public awareness grows about the link between ultra-processed foods and health issues like obesity, diabetes, and even addiction, many people are beginning to ask tough questions about the food industry’s role. Were these foods designed to be addictive? Can food...
May 1, 2025 | Chemical Injuries, Chemical Injury, Defective Product, Formaldehyde Exposure, Product Liability, Workplace Injuries, Wrongful Death
Formaldehyde is a colorless, strong-smelling chemical that is widely used in manufacturing, construction, healthcare, and cosmetics. While it serves important purposes in industrial and consumer products, formaldehyde is also a known toxic substance with serious...
Apr 24, 2025 | Defective Drugs, Defective Medical Device, Defective Product, Depo-Provera, Product Liability
For decades, Depo-Provera has been marketed as a convenient and long-lasting form of birth control. The injectable contraceptive, also known as depot medroxyprogesterone acetate (DMPA), has been widely prescribed to millions of women in the United States and around...
Apr 7, 2025 | Defective Medical Device, Defective Product, Medical News, PowerPort Injuries, Product Liability
The Bard PowerPort, an implantable port catheter designed for patients requiring frequent or long-term intravenous treatments, has recently come under scrutiny due to reports of device failures leading to serious injuries. Patients and their families have initiated...
Apr 1, 2025 | Defective Drugs, Defective Product, Ozempic Injury, Ozempic Lawsuit, Ozempic Lawsuits, Product Liability
Weight loss injections, such as Ozempic, Wegovy, and Mounjaro, have surged in popularity due to their effectiveness in helping individuals lose weight. However, these medications have also been linked to serious side effects and complications, prompting lawsuits from...
Mar 26, 2025 | Defective Medical Device, Defective Product, Medical News, Product Liability
In December 2024, the U.S. Food and Drug Administration (FDA) approved Humacyte’s SYMVESS™, an acellular tissue-engineered vessel designed for use in adult patients requiring vascular repair due to extremity trauma. This approval marks a significant advancement...
